MIR1185-1: A Drug Target / Disease Biomarker (G100302157)
MIR1185-1: A Drug Target / Disease Biomarker
MIR1185-1 is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and gastrointestinal tract. It is a member of the MIR family of proteins, which are known for their role in intracellular signaling.
One of the functions of MIR1185-1 is to regulate the levels of glucose in the body. MIR1185-1 is known to interact with the protein S6, which is a key regulator of glucose metabolism. When glucose levels are high, MIR1185-1 helps to lower them by promoting the breakdown of glucose-carrying molecules in the body.
Another function of MIR1185-1 is to regulate the levels of lipids in the body. MIR1185-1 has been shown to interact with the protein Apolipoprotein A-1 (APA1), which is a protein that is involved in lipid metabolism. When levels of APA1 are low, MIR1185-1 helps to increase them by promoting the production of APA1 in the body.
MIR1185-1 has also been shown to play a role in the development and progression of various diseases, including cancer. For example, studies have shown that MIR1185-1 is often overexpressed in tissues of cancer cells, and that inhibiting its activity may be a potential therapeutic approach.
In addition to its role in cell signaling, MIR1185-1 is also of interest as a potential drug target. For example, because MIR1185-1 is involved in glucose and lipid metabolism, drugs that can inhibit these processes may be effective in treating various diseases, including diabetes, cancer, and obesity.
In conclusion, MIR1185-1 is a protein that is expressed in various tissues of the body and is involved in a variety of cellular processes, including cell signaling and glucose and lipid metabolism. Its potential as a drug target makes it an attractive target for researchers to investigate and develop new treatments for a variety of diseases.
Protein Name: MicroRNA 1185-1
The "MIR1185-1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1185-1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR1185-2 | MIR1193 | MIR1197 | MIR1199 | MIR1200 | MIR1202 | MIR1203 | MIR1204 | MIR1205 | MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1
